
TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 125
IS  - S2
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.13297
DO  - doi:10.1111/bcpt.13297
SP  - 3
EP  - 330
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 50
IS  - S41
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23297
DO  - doi:10.1002/ppul.23297
SP  - S193
EP  - S453
PY  - 2015
ER  - 

C7  - pp. 567-684
TI  - Microbes as a Tool for Industry and Research
SN  - 9780470905944
UR  - https://doi.org/10.1002/9781118311912.ch7
DO  - doi:10.1002/9781118311912.ch7
SP  - 567-684
KW  - fermentation
KW  - antibiotics
KW  - industrial fermentation
KW  - strain development
KW  - postgenomic era
KW  - molecular diagnostics technology
KW  - rDNA pharmaceuticals
KW  - aptamers
KW  - immundiagnostics
KW  - reporter genes
KW  - Human Genome Project
KW  - prognostics
KW  - diagnostics
KW  - therapeutics
KW  - pharmacogenomics
KW  - fermentation scale-up
KW  - immobilized enzymes
KW  - single cell protein
KW  - fermented food
KW  - mushroom
KW  - beverages
KW  - food diagnostics
KW  - foodborne microbial diseases
KW  - bacterial counts
KW  - microbial spoilage of canned food
KW  - refrigerated meat
KW  - fermented food
KW  - fermented milk products
KW  - direct microscopic count of organisms in milk
KW  - biosensors
KW  - food preservation
KW  - microbial sampling
KW  - food poisoning
KW  - foodborne diseases and microbial sampling
KW  - staphylococcal food poisoning
KW  - Clostridium food poisoning
KW  - food diagnostics
KW  - salmonellosis
KW  - Campylobacter
KW  - listeriosis
PY  - 2015
AB  - Summary This chapter contains sections titled: Prologue Historical Development Clinical Diagnostics in a New Era Industrial Microorganisms and Product Formation Major Industrial Products for Health and Industry Food Diagnostics, Food Preservation, and Foodborne Microbial Diseases Future Challenges: Next Generation Diagnostics Industry References
ER  - 

TY  - JOUR
TI  - ADF Abstracts 2012
JO  - Experimental Dermatology
VL  - 21
IS  - 3
SN  - 9780470905944
UR  - https://doi.org/10.1111/j.1600-0625.2011.01428.x
DO  - doi:10.1111/j.1600-0625.2011.01428.x
SP  - e1
EP  - e58
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S3
SN  - 9780470905944
UR  - https://doi.org/10.1111/ajt.14306
DO  - doi:10.1111/ajt.14306
SP  - 411
EP  - 815
PY  - 2017
ER  - 

AU  - Tetradis, Sotirios
AU  - McCauley, Laurie
AU  - Aghaloo, Tara
C7  - pp. 927-932
TI  - Osteonecrosis of the Jaw
SN  - 9781119266563
UR  - https://doi.org/10.1002/9781119266594.ch120
DO  - doi:10.1002/9781119266594.ch120
SP  - 927-932
KW  - antiresorptive agents
KW  - ONJ
KW  - osseous tissue
KW  - patient symptomatology
KW  - risk factors
PY  - 2017
AB  - Summary The precise etiology of osteonecrosis of the jaw (ONJ) is unknown and likely complex. Antiresorptive agents, notably bisphosphonates and denosumab, are associated with ONJ. Other pharmacological modifiers including immunomodulators and antiangiogenic agents increase the risk of ONJ. In general, local factors that disrupt oral soft and hard tissue integrity or systemic factors that compromise healing have been shown to contribute to ONJ development, progression, and severity. Potent antiresorptive agents, such as zoledronate, alendronate, and denosumab, are risk factors for ONJ because of the potential negative impact on the underlying osseous tissue. Patient symptomatology ranges from nearly absent to mild tenderness to severe pain and discomfort. Treatment protocols range from conservative oral microbial mouthrinses to aggressive segmental resection with microvascular reconstruction. Clinical studies have provided valuable information towards understanding ONJ incidence in various patient cohorts and identifying local and systemic risk factors.
ER  - 

C7  - pp. 59-281
TI  - Section 3: Diseases
SN  - 9781444335675
UR  - https://doi.org/10.1002/9781444346961.ch3
DO  - doi:10.1002/9781444346961.ch3
SP  - 59-281
KW  - anthrax
KW  - Burkholderia
KW  - Campylobacter
KW  - cholera
KW  - stool samples
KW  - VRE
KW  - delta hepatitis
KW  - mumps
KW  - Mycoplasma
KW  - norovirus
PY  - 2017
AB  - Summary This chapter contains sections titled: Amoebic dysentery Anthrax Bacillus cereus Botulism Brucellosis Burkholderia Campylobacter Chickenpox and shingles (varicella-zoster infections) Chikungunya Chlamydophila pneumoniae Chlamydophila psittaci Chlamydia trachomatis (genital) Cholera Creutzfeldt?Jakob disease and other human transmissible spongiform encephalopathies Clostridium difficile Clostridium perfringens Coxsackievirus infections Cryptosporidiosis Cyclosporiasis Cytomegalovirus Dengue fever Diphtheria Encephalitis, acute Enterococci, including glycopeptide-resistant enterococci Epstein?Barr virus Escherichia coli O157 (and other E. coli gastroenteritis) Giardiasis Gonorrhoea, syphilis and other acute STIs Hantavirus Head lice Helicobacter pylori Hepatitis A Hepatitis B Hepatitis C Delta hepatitis Hepatitis E Herpes simplex Haemophilus influenzae type b HIV Influenza Japanese B encephalitis Kawasaki disease Legionellosis Leprosy Leptospirosis Listeria Lyme disease Malaria Measles Meningococcal infection Molluscum contagiosum Methicillin-resistant Staphylococcus aureus (MRSA) Mumps Mycoplasma Norovirus Paratyphoid fever Parvovirus B19 (fifth disease) Plague Pneumococcal infection Poliomyelitis Q fever Rabies Relapsing fever Respiratory syncytial virus Ringworm Rotavirus Rubella Salmonellosis Severe acute respiratory syndrome (SARS) Scabies Shigella Smallpox Staphylococcal food poisoning Streptococcal infections Tetanus Threadworms Tick-borne encephalitis Toxocara Toxoplasmosis Tuberculosis Tularaemia Typhoid fever Typhusx, other Rickettsia, Ehrlichia and Bartonella Vibrio parahaemolyticus Viral haemorrhagic fevers Warts and verrucae West Nile virus Whooping cough Yellow fever Yersiniosis Other organisms
ER  - 

TY  - JOUR
C8  - TME-2019-0033.R1
TI  - Abstracts-Speaker Sessions
JO  - Transfusion Medicine
JA  - Transfusion Med
VL  - 29
IS  - S2
SN  - 9781444335675
UR  - https://doi.org/10.1111/tme.12635
DO  - doi:10.1111/tme.12635
SP  - 3
EP  - 24
PY  - 2019
ER  - 

TY  - JOUR
TI  - RSA ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 30
IS  - s1
SN  - 9781444335675
UR  - https://doi.org/10.1111/j.1530-0277.2006.00150.x
DO  - doi:10.1111/j.1530-0277.2006.00150.x
SP  - 7A
EP  - 234A
PY  - 2006
ER  - 

TY  - JOUR
AU  - Guo, Xin-Xin
AU  - Zou, Xiao-Huan
AU  - Wang, Chong
AU  - Yao, Xiang-Ping
AU  - Su, Hui-Zhen
AU  - Lai, Lu-Lu
AU  - Chen, Hai-Ting
AU  - Lai, Jing-Hui
AU  - Liu, Yao-Bin
AU  - Chen, Dong-Ping
AU  - Deng, Yu-Chun
AU  - Lin, Pan
AU  - Lin, Hua-Song
AU  - Hong, Bing-Cong
AU  - Yao, Qing-Yang
AU  - Chen, Xue-Jiao
AU  - Huang, Dan-Qin
AU  - Fu, Hong-Xia
AU  - Peng, Ji-Dong
AU  - Niu, Yan-Fang
AU  - Zhao, Yu-Ying
AU  - Zhu, Xiao-Qun
AU  - Lu, Xiao-Pei
AU  - Lin, Hai-Liang
AU  - Li, Yong-Kun
AU  - Liu, Chang-Yun
AU  - Huang, Gen-Bin
AU  - Wang, Ning
AU  - Chen, Wan-Jin
TI  - Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcification
JO  - Human Mutation
JA  - Human Mutation
VL  - 40
IS  - 4
SN  - 9781444335675
UR  - https://doi.org/10.1002/humu.23703
DO  - doi:10.1002/humu.23703
SP  - 392
EP  - 403
KW  - primary familial brain calcification
KW  - PFBC
KW  - mutation spectrum
KW  - SLC20A2
KW  - XPR1
KW  - functional assay
PY  - 2019
AB  - Abstract Primary familial brain calcification (PFBC) is a rare neurodegenerative disorder with four causative genes (SLC20A2, PDGFRB, PDGFB, and XPR1) that have been identified. Here, we aim to describe the mutational spectrum of four causative genes in a series of 226 unrelated Chinese PFBC patients. Mutations in four causative genes were detected in 16.8% (38/226) of PFBC patients. SLC20A2 mutations accounted for 14.2% (32/226) of all patients. Mutations in the other three genes were relatively rare, accounting for 0.9% (2/226) of all patients, respectively. Clinically, 44.8% of genetically confirmed patients (probands and relatives) were considered symptomatic. The most frequent symptoms were chronic headache, followed by movement disorders and vertigo. Moreover, the total calcification score was significantly higher in the symptomatic group compared to the asymptomatic group. Functionally, we observed impaired phosphate transport induced by seven novel missense mutations in SLC20A2 and two novel mutations in XPR1. The mutation p.D164Y in XPR1 might result in low protein expression through an enhanced proteasome pathway. In conclusion, our study further confirms that mutations in SLC20A2 are the major cause of PFBC and provides additional evidence for the crucial roles of phosphate transport impairment in the pathogenies of PFBC.
ER  - 

TY  - JOUR
TI  - Abstracts of the papers presented at the 44th Annual Meeting of the American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
VL  - 35
IS  - 1
SN  - 9781444335675
UR  - https://doi.org/10.1111/j.1600-0560.2007.00929.x
DO  - doi:10.1111/j.1600-0560.2007.00929.x
SP  - 91
EP  - 168
PY  - 2008
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF SUBMISSIONS ACCEPTED FOR PRESENTATIOIN
JO  - Journal of General Internal Medicine
VL  - 20
IS  - S1
SN  - 9781444335675
UR  - https://doi.org/10.1111/j.1525-1497.2005.020S1.x
DO  - doi:10.1111/j.1525-1497.2005.020S1.x
SP  - 25
EP  - 279
PY  - 2005
ER  - 

TY  - JOUR
TI  - Wednesday 18 January 2012
JO  - Developmental Medicine & Child Neurology
VL  - 54
IS  - s1
SN  - 9781444335675
UR  - https://doi.org/10.1111/j.1469-8749.2011.04191.x
DO  - doi:10.1111/j.1469-8749.2011.04191.x
SP  - 20
EP  - 54
PY  - 2012
ER  - 

TY  - JOUR
TI  - Program of the Thirty-third Meeting of The American Society of Primatologists
JO  - American Journal of Primatology
JA  - Am. J. Primatol.
VL  - 72
IS  - S1
SN  - 9781444335675
UR  - https://doi.org/10.1002/ajp.20862
DO  - doi:10.1002/ajp.20862
SP  - 1
EP  - 78
PY  - 2010
ER  - 

AU  - Razin, Shmuel
TI  - Mycoplasma
SN  - 9780470686386
UR  - https://doi.org/10.1002/9780470688618.taw0077
DO  - doi:10.1002/9780470688618.taw0077
KW  - Mycoplasma
KW  - Mycoplasmas-phenotypically distinguished by minute size and total lack of cell wall
KW  - mycoplasma-like organisms (MLO)
KW  - cellular morphology and cytoskeletal elements
KW  - cocultivation with cell cultures
KW  - mycoplasmas infecting cell cultures
KW  - intraspecies genetic heterogeneity
KW  - proteome and transcriptome analyses and bioinformatics
PY  - 2010
AB  - Abstract
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 84
IS  - S2
SN  - 9780470686386
UR  - https://doi.org/10.1002/bjs.1800841402
DO  - doi:10.1002/bjs.1800841402
SP  - 1
EP  - 168
PY  - 1997
ER  - 

TY  - JOUR
TI  - All Poster Abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 100
IS  - s7
SN  - 9780470686386
UR  - https://doi.org/10.1002/bjs.9239
DO  - doi:10.1002/bjs.9239
SP  - 115
EP  - 225
PY  - 2013
ER  - 

AU  - McHugh, D. P.
C7  - pp. 382-413
TI  - Theatre Practice
SN  - 9780632057276
UR  - https://doi.org/10.1002/9780470690543.ch19
DO  - doi:10.1002/9780470690543.ch19
SP  - 382-413
KW  - sterilisation
KW  - equine veterinary nurse
KW  - vacuum-assisted autoclave
KW  - endoscopy equipment
KW  - toxicity
PY  - 2013
AB  - Summary This chapter contains section titled: Factors that may Affect the Development of Infection Sterilisation The Operating Theatre Maintenance and Cleaning of Operating Theatre Surgical Team Preparation Conduct During Surgery Pre-Operative Preparation of the Patient (see Chapter 20) Instruments and Equipment Suture Materials Special Equipment Reading List
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Philadelphia, PA, October 25-28, 2014
JO  - Transfusion
JA  - Transfusion
VL  - 54
IS  - S2
SN  - 9780632057276
UR  - https://doi.org/10.1111/trf.12845
DO  - doi:10.1111/trf.12845
SP  - 15A
EP  - 268A
PY  - 2014
ER  - 

TY  - JOUR
TI  - ALLIED HEALTH PROFESSIONALS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780632057276
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_1.x
DO  - doi:10.1111/j.1479-8077.2006.00199_1.x
SP  - A21
EP  - A25
PY  - 2006
ER  - 
